Purchase Order 75N98024P01207
- Not listed
- This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit organization and manufacturer of sequencing and genomic analysis solutions. The contract, valued at $112,216.00, is for the purchase of Illumina's sequencing systems, reagents, and other products to support genomic research and diagnostics. The contract is a firm fixed price purchase order with no set-aside designation....
- This federal contract was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis equipment and reagents. The $135,680.40 firm fixed price contract is for the delivery of Illumina's sequencing systems, reagents, and related services to support genomic research and analysis across various government agencies. The award has no set-aside designation. Illumina has...
- This federal contract award to Illumina, Inc. was issued by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH). The $159,746.65 firm fixed price delivery order contract is for the provision of Illumina's proprietary sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis. This appears to be a follow-on to previous prime contracts Illumina has held with various federal agencies for similar...
- This is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $97,800.00, is for the procurement of PARTEK software. It does not have a set-aside designation. The award is part of Illumina's broader federal contract and grant portfolio, which includes Indefinite Delivery Vehicles (IDVs) with the...
- This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The award, valued at $10,331.78, is a delivery order placed under a larger federal contract vehicle. The award is for Illumina to provide sequencing systems, reagents, and related services to support genomic sequencing and analysis for the National Human Genome Research Institute, which is part of the National Institutes of Health (NIH), a civilian agency. The...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $21,323.61 contract is for the provision of various Illumina sequencing systems, reagents, and related maintenance services to support genomic research and analysis across federal agencies. Illumina has a history of prime federal contract awards...
- This federal contract award was issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $20,663.57 firm fixed price delivery order provides Illumina sequencing systems, reagents, and related goods and services to support genomic sequencing and analysis for research and diagnostic purposes across various federal agencies. Illumina has a history of prior prime contract awards with the NIH, CDC, USDA, VA, and...
- This is a firm fixed price delivery order awarded to Illumina, Inc. by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health. The $149,950.32 contract is for the provision of Illumina's genomic sequencing systems, reagents, and related services to support research and diagnostic applications. Illumina has a history of providing sequencing products and services to federal agencies including the NIH, CDC, USDA, and VA. The award is not...
- This federal contract award to Illumina, Inc., a manufacturer of genomic sequencing instruments and related products, was issued by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences. The $104,624.89 firm fixed-price delivery order is for the provision of various Illumina sequencing systems, reagents, consumables, and support services to support the agency's genomic research and diagnostic efforts. The award does...
- This is a firm fixed price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The $103,374.14 contract is for the provision of Illumina's sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic purposes. The contract has no set-aside designation. Illumina has previously been awarded prime...
This federal contract award is for a 12-month subscription to the Partek Genomics Suite software from Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $81,846.00, was awarded by the Department of Health and Human Services' National Institutes of Health Office of the Director, and does not include a set-aside designation. Illumina has a history of providing sequencing systems, reagents, and bioinformatics products to support genomic research and diagnostics across various federal agencies, including the NIH, CDC, USDA, and VA. While no subcontractors are mentioned in the provided information, Illumina has previously been issued subcontracts by prime partners such as Triad National Security and Battelle Memorial Institute. The company also holds an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to support nucleic acid sequencing needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $81.8k | 5/6/24 |